Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(2):e212-e214. Published online February 10, 2025

DOI: https://doi.org/10.3350/cmh.2025.0100

View: 723 Download: 21

Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(2):e161-e162. Published online February 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0121

View: 736 Download: 29

Editorial

Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(1):301-303. Published online August 30, 2024

DOI: https://doi.org/10.3350/cmh.2024.0716

View: 1457 Download: 81 Web of Science: 1 Crossref: 2

Original Article

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi

Clin Mol Hepatol. 2025;31(1):131-146. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0451

View: 1938 Download: 191 Web of Science: 4 Crossref: 2

Snapshot

HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?

Soon Kyu Lee, Jung Hyun Kwon

Clin Mol Hepatol. 2023;29(3):825-827. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0185

View: 4301 Download: 107 Web of Science: 3 Crossref: 3

Letter to the Editor

Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study

Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung

Clin Mol Hepatol. 2022;28(4):926-928. Published online September 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0233

View: 3482 Download: 80 Web of Science: 2 Crossref: 3

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2020;26(1):78-82. Published online November 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0078

View: 7415 Download: 184 Web of Science: 6 Crossref: 5

Original Article

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Hyo Jun Ahn

Clin Mol Hepatol. 2018;24(4):409-416. Published online August 27, 2018

DOI: https://doi.org/10.3350/cmh.2018.0034

View: 12868 Download: 259 Web of Science: 20 Crossref: 20

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2017;23(2):128-137. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2016.0071

View: 12816 Download: 196 Web of Science: 30 Crossref: 26

1 |

Viewed By 12009	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7526	MAFLD: How is it different from NAFLD?
Viewed By 6589	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5778	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5399	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search